Access cutting-edge follicular lymphoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access follicular lymphoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related follicular lymphoma treatment provided free
This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL). This study will be made up of two parts: Part 1 (non-randomized) and Part 2 (randomized - controlled). The aim of Part 1 of the study is to see how safe and tolerable the study drug is when given alone. The aim of Part 2 of the study is to see how the study drug works compared
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this follicular lymphoma clinical trial in New York, NY
If you're searching for follicular lymphoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced follicular lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.